Mar 9 2010
Varian, Inc. (Nasdaq GS: VARI) announced today that Bruker Corporation (Nasdaq: BRKR) and Agilent Technologies, Inc. (NYSE: A) have entered into a definitive asset purchase agreement pursuant to which Bruker will acquire certain product lines of Varian. As previously announced, Agilent committed to divest those product lines in connection with obtaining regulatory approval for Agilent's pending acquisition of Varian.
The product lines to be acquired by Bruker are:
- Varian's inductively coupled plasma mass spectrometry (ICP-MS) instruments business;
- Varian's laboratory gas chromatography (Lab GC) instruments business; and
- Varian's gas chromatography triple-quadrupole mass spectrometry (GC-MS QQQ) instruments business.
Agilent and Bruker announced that their transaction is subject to customary closing conditions and regulatory approvals, and is expected to close shortly after Agilent completes its acquisition of Varian (which Agilent anticipates will occur by April 30, 2010, following regulatory approvals).
SOURCE Varian, Inc.
Nine-year study reveals lipids' pivotal role in aging, health, and disease